Rich Kurz Speaking at the 2025 IPO Annual Meeting

On Tuesday, September 9th, Partner Richard Kurz will be speaking in a panel discussion at the IPO Annual 2025 meeting titled “The Role of Patents in Pharmaceutical Innovation, Drug Pricing, and Market Exclusivity”.

Drawing on legal frameworks, economic data, and case studies, the discussion will clarify the nuanced relationship between intellectual property protection and public health outcomes. The panel aims to provide a balanced perspective that underscores the importance of robust patent systems for sustaining pharmaceutical innovation while addressing concerns about accessibility and affordability.

The IPO Annual Meeting will take place at the Manchester Grand Hyatt in San Diego, CA from September 7-9. Visit www.ipo.org/am2025 to register or for additional info.